Login / Signup

How low is really low? Comparison of two C-peptide assays to establish residual C-peptide production in type 1 diabetes.

Kitty de LeurCharlotte E VollenbrockPim DekkerMartine de VriesErwin BirnieDick MulBruce H R WolffenbuttelJoost GroenHenk-Jan AanstootLianne S M Boesten
Published in: Diabetic medicine : a journal of the British Diabetic Association (2022)
The IRMA provided the lowest threshold for quantification of serum C-peptide. LoQ of commercially available assays should be established in-house before applying them in research studies and clinical trials in which low C-peptide levels have clinical or scientific relevance.
Keyphrases
  • high throughput
  • type diabetes
  • clinical trial
  • glycemic control
  • skeletal muscle